| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| WERNER ROBERT F. | Chief Accounting Officer | C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD, SOUTH SAN FRANCISCO | /s/ Kendra Fox, as Attorney-in-Fact for Robert F. Werner | 05 Feb 2026 | 0001590947 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TWST | Common Stock | Sale | $8,151 | -175 | -0.27% | $46.58 | 65,738 | 03 Feb 2026 | Direct | F1 |
| transaction | TWST | Common Stock | Sale | $319,536 | -7,000 | -11% | $45.65 | 58,738 | 04 Feb 2026 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
| F2 | Represents the weighted average sales price per share. The shares sold at prices ranging from $45.61 to $45.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |